Modernizing biomanufacturing methods and reducing regulatory burdens are key landmarks on India’s roadmap for expanding biosimilars development.

Why enterprise AI agents could become the ultimate insider threat ...

In 2026, the competitive edge isn't where your data sits, but how fast it moves. We compare how the top five platforms are ...

Jill Blumberg of Practical Law asked leading real estate practitioners to share their thoughts on recent developments impacting the US commercial real estate market.

Recent transactions make clear that large pharmaceutical companies now view rare disease as a core area for sustained growth, rather than episodic deal-making. BioMarin’s acquisition of Amicus ...

Guidance for Q1 2026 -- Net revenue forecast between RMB 1.578 billion and RMB 1.598 billion, or 5.7%-7% growth rate, with ...

Inflight connectivity is evolving from a luxury to a fundamental passenger expectation, transforming the aircraft into a ...

The Israeli bombing that killed Iran’s Supreme Leader, Ayatollah Ali Khamenei, on Saturday not only brought the demise of one ...

In a corporate boardroom reviewing a high-stakes multinational deal, every financial risk was dissected ­— but no one in the room could see the classified ...

Together, these findings indicate that astrocytes undergo profound sex- and region-specific adaptations to chronic ethanol, implicating extracellular matrix and glycosaminoglycan remodeling as key ...

Building functional human muscle in the laboratory has long been a goal of regenerative medicine, but one stubborn obstacle remains: real muscle is not just a mass of cells. Its strength and function ...

Cash Burn -- $50.2 million in 2025, an improvement from $57.8 million in 2024 due to lower headcount and development costs.